Table 2.
No. | Mol. Mass | Assigned composition | Relative amount (mean ± SD) | ||
---|---|---|---|---|---|
Cancer | Benign | Normal | |||
1 | 1689.8237 | (HexNAc)1(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 0.05 ± 0.06 | 0.00 ± 0.00 | 0.06 ± 0.08 |
2 | 1746.7541 | (HexNAc)2 + (Man)3(GlcNAc)2 | 0.16 ± 0.17 | 0.27 ± 0.23 | 0.09 ± 0.11 |
3 | 1851.8935 | (Hex)1(HexNAc)1(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
4 | 1892.8917 | (HexNAc)2(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 38.23 ± 7.89 | 34.01 ± 3.36 | 27.37 ± 1.84 |
5 | 1908.8931 | (Hex)1(HexNAc)2 + (Man)3(GlcNAc)2 | 0.39 ± 0.13 | 0.58 ± 0.42 | 0.12 ± 0.12 |
6 | 2054.9466 | (Hex)1(HexNAc)2(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 48.47 ± 2.71 | 53.33 ± 1.54 | 53.03 ± 3.00 |
7 | 2070.9392 | (Hex)2(HexNAc)2 + (Man)3(GlcNAc)2 | 0.13 ± 0.18 | 0.16 ± 0.18 | 0.10 ± 0.08 |
8 | 2095.9783 | (HexNAc)3(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 1.48 ± 0.67 | 1.53 ± 0.54 | 1.60 ± 0.77 |
9 | 2216.9994 | (Hex)2(HexNAc)2(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 6.16 ± 1.74 | 6.95 ± 2.17 | 11.27 ± 2.79 |
10 | 2258.0164 | (Hex)1(HexNAc)3(Deoxyhexose)1 + (Man)3(GlcNAc)2 | 1.05 ± 0.17 | 1.42 ± 0.54 | 1.24 ± 0.46 |
11 | 2360.0530 | (Hex)1(HexNAc)2(Deoxyhexose)1(NeuAc)1 + (Man)3(GlcNAc)2 | 0.23 ± 0.00 | 0.19 ± 0.09 | 0.27 ± 0.19 |
12 | 2522.0977 | (Hex)2(HexNAc)2(Deoxyhexose)1(NeuAc)1 + (Man)3(GlcNAc)2 | 1.09 ± 0.41 | 0.94 ± 0.43 | 2.08 ± 0.98 |
13 | 2828.2742 | (Hex)2(HexNAc)2(Deoxyhexose)1(NeuAc)2 + (Man)3(GlcNAc)2 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
GlcNAc: N‐acetylglucosamine; Man: mannose; Neu5Ac: N‐acetylneuraminic acid; GalNAc: N‐acetylgalactosamine; HexNAc, N‐acetylhexosamine.